Andrew Kenneth William Powell insider trades: Aclaris Therapeutics (ACRS) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Andrew reports to the SEC
and 3 more companies
Open-market buys and sales
15 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 4, 2024 | ACRS | ↑ Buy | 14,500 | $1.24 | $18K | Direct | Mar 5, 2024 (1d) |
| Jan 11, 2019 | LNDC | ↑ Buy | 525 | $11.62 | $6K | Direct | Jan 14, 2019 (3d) |
| May 16, 2018 | ACRS | ↑ Buy | 500 | $19.12 | $10K | Direct | May 17, 2018 (1d) |
| Jun 6, 2016 | MDVN | ↓ Sell | 2,578 | $60.42 | $156K | Direct | Jun 6, 2016 (0d) |
| Sep 2, 2014 | ITMN | ↓ Sell | 7,500 | $73.47 | $551K | Direct | Sep 3, 2014 (1d) |
| May 30, 2014 | ITMN | ↓ Sell | 1,000 | $39.44 | $39K | Direct | Jun 3, 2014 (4d) |
| Jul 15, 2011 | CRTX | ↓ Sell | 2,000 | $8.63 | $17K | Direct | Jul 18, 2011 (3d) |
| Apr 4, 2011 | CRTX | ↓ Sell10b5-1 | 2,000 | $6.53 | $13K | Direct | Apr 6, 2011 (2d) |
| Jan 7, 2011 | CRTX | ↓ Sell10b5-1 | 2,000 | $5.73 | $11K | Direct | Jan 10, 2011 (3d) |
| Nov 1, 2010 | CRTX | ↓ Sell10b5-1 | 7,900 | $6.28 | $50K | Direct | Nov 2, 2010 (1d) |
| Nov 28, 2007 | CGPI | ↑ Buy | 200 | $7.30 | $1K | By Trust | Nov 30, 2007 (2d) |
| Nov 16, 2007 | CGPI | ↑ Buy | 400 | $8.01 | $3K | Direct | Nov 20, 2007 (4d) |
| Nov 8, 2007 | CGPI | ↑ Buy | 250 | $8.44 | $2K | By Trust | Nov 13, 2007 (5d) |
| Nov 8, 2007 | CGPI | ↑ Buy | 200 | $8.50 | $2K | Direct | Nov 13, 2007 (5d) |
| May 22, 2007 | CGPI | ↑ Buy | 200 | $10.48 | $2K | By Trust | May 24, 2007 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ACRS insiders
Open-market trades in the last 12 months
About Andrew Kenneth William Powell's insider trades
Andrew Kenneth William Powell is an insider at Aclaris Therapeutics (ACRS). Since May 22, 2007, Andrew has reported 8 open-market purchases worth $44K and 7 sales worth $838K on SEC Form 4. There have been no open-market trades in the last 12 months.
3 sales (9% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include grants and awards (36 filings), option exercises (13 filings), gifts (5 filings), shares returned to the company (5 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ACRS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.